PolarityTE, Inc. operates as commercial-stage biotechnology and regenerative biomaterials company in the United States. The company focuses on discovering, designing and developing a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences. Its PolarityTE platform would be able to provide transform tissue regeneration, including potential regeneration of multiple tissue substrates, such as skin, bone, muscle, fat, cartilage, nerves, and blood vessels, as well as neural elements, solid and hollow organ composite tissue systems. The company is headquartered in Salt Lake City, Utah.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Prepackaged software
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:COOL
CUSIPN/A
Phone385-237-2279
Debt
Debt-to-Equity RatioN/A
Current Ratio12.72
Quick Ratio12.72
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$6.69 million
Price / Sales81.38
Cash FlowN/A
Price / CashN/A
Book Value($17.19) per share
Price / Book-1.49
Profitability
EPS (Most Recent Fiscal Year)N/A
Net Income$-130,820,000.00
Net MarginsN/A
Return on EquityN/A
Return on Assets-189.63%
Miscellaneous
Employees33
Outstanding Shares21,300,000
Market Cap$506.62 million
Polarityte (NASDAQ:COOL) Frequently Asked Questions
What is Polarityte's stock symbol?
Polarityte trades on the NASDAQ under the ticker symbol "COOL."
How were Polarityte's earnings last quarter?
Polarityte Inc (NASDAQ:COOL) issued its quarterly earnings data on Thursday, June, 14th. The company reported ($1.47) earnings per share (EPS) for the quarter. View Polarityte's Earnings History.
When is Polarityte's next earnings date?
What price target have analysts set for COOL?
1 brokerages have issued twelve-month price objectives for Polarityte's stock. Their forecasts range from $65.00 to $65.00. On average, they expect Polarityte's stock price to reach $65.00 in the next twelve months. This suggests a possible upside of 154.3% from the stock's current price. View Analyst Price Targets for Polarityte.
What is the consensus analysts' recommendation for Polarityte?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Polarityte in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Polarityte.
What are Wall Street analysts saying about Polarityte stock?
Here are some recent quotes from research analysts about Polarityte stock:
- 1. According to Zacks Investment Research, "PolarityTE, Inc. creates regenerative medicine and provides tissue engineering platform. It develops and obtains regulatory approval for technology which utilizes a patient's own tissue substrates for regeneration of skin, bone, muscle, cartilage and nerves. The product pipeline comprises SkinTE, OsteoTE, AngioTE, MyoTE, CarteTE, AdiposeTE and NeuralTE. PolarityTE, Inc., formerly known as Majesco Entertainment Company, is headquatered in Salt lake City, Utah. " (8/14/2018)
- 2. Cantor Fitzgerald analysts commented, "We believe that PolarityTE can revolutionize the field of regenerative medicine. We think SkinTE can achieve over $600 million revenue from the currently built out facility, with perhaps multiples of this number when adding bone, cartilage, heart and muscle products in development. $65/sh price target is derived from the combined risk-adjusted NPV of the future cash flows from the SkinTE product and an enterprise value for the follow-on product lines." (7/25/2018)
Who are some of Polarityte's key competitors?
Some companies that are related to Polarityte include Varonis Systems (VRNS), Hortonworks (HDP), Progress Software (PRGS), Talend (TLND), Cango (CANG), SPS Commerce (SPSC), Carbon Black (CBLK), MicroStrategy (MSTR), Imperva (IMPV), Apptio (APTI), Everbridge (EVBG), LivePerson (LPSN), Rapid7 (RPD), SendGrid (SEND) and Web.com Group Inc. common stock (WEB).
Who are Polarityte's key executives?
Polarityte's management team includes the folowing people:
- Mr. John Stetson, CFO, Exec. VP, Sec. & Director (Age 33)
- Dr. Denver M. Lough, Chairman, CEO & Chief Scientific Officer (Age 37)
- Dr. Edward Winslow Swanson M.D., COO & Director (Age 33)
- Mr. Rich Haerle, VP of Investor Relations & Strategy
- Mr. Cameron J. Hoyler J.D., Gen. Counsel (Age 34)
Has Polarityte been receiving favorable news coverage?
Media stories about COOL stock have been trending somewhat positive on Monday, Accern Sentiment reports. The research firm identifies positive and negative press coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Polarityte earned a media and rumor sentiment score of 0.20 on Accern's scale. They also assigned media coverage about the company an impact score of 46.66 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the near future. View Recent Headlines for Polarityte.
Who are Polarityte's major shareholders?
Polarityte's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Gilder Gagnon Howe & Co. LLC (4.03%), DSAM Partners London Ltd (3.82%), Opaleye Management Inc. (3.76%), FMR LLC (3.43%), BlackRock Inc. (3.35%) and RTW Investments LP (2.00%). Company insiders that own Polarityte stock include Barry C Honig, Edward Winslow Swanson, Jeffrey Hansen Dyer, John Stetson, Michael Martin Beeghley and Peter A Cohen. View Institutional Ownership Trends for Polarityte.
Which institutional investors are selling Polarityte stock?
Which institutional investors are buying Polarityte stock?
COOL stock was acquired by a variety of institutional investors in the last quarter, including DSAM Partners London Ltd, Opaleye Management Inc., FMR LLC, Gilder Gagnon Howe & Co. LLC, BlackRock Inc., RTW Investments LP, Ardsley Advisory Partners and Kavi Asset Management LP. Company insiders that have bought Polarityte stock in the last two years include Barry C Honig, Edward Winslow Swanson, Jeffrey Hansen Dyer, John Stetson, Michael Martin Beeghley and Peter A Cohen. View Insider Buying and Selling for Polarityte.
How do I buy shares of Polarityte?
Shares of COOL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Polarityte's stock price today?
One share of COOL stock can currently be purchased for approximately $25.56.
How big of a company is Polarityte?
Polarityte has a market capitalization of $506.62 million and generates $6.69 million in revenue each year. Polarityte employs 33 workers across the globe.
How can I contact Polarityte?
Polarityte's mailing address is 1960 S 4250 W, SALT LAKE CITY UT, 84104. The company can be reached via phone at 385-237-2279 or via email at [email protected]
MarketBeat Community Rating for Polarityte (NASDAQ COOL)
MarketBeat's community ratings are surveys of what our community members think about Polarityte and other stocks. Vote "Outperform" if you believe COOL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe COOL will underperform the S&P 500 over the long term. You may vote once every thirty days.
